LNTH
Lantheus Holdings, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$99.92
+0.12%Margins
Gross margin
60.1%
EBITDA margin
30.3%
EBIT margin
19.4%
Net margin
17.7%
FCF margin
24.9%
21.0%
Return on equity
11.4%
Return on assets
15.6%
Return on invested capital
0.65x
Asset turnover
$412.8M
Cash from operations
$9.09
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026